These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 28578587)

  • 1. Next-Generation Magnetic Resonance Imaging Contrast Agents.
    Morrow JR; Tóth É
    Inorg Chem; 2017 Jun; 56(11):6029-6034. PubMed ID: 28578587
    [No Abstract]   [Full Text] [Related]  

  • 2. Correction to Next-Generation Magnetic Resonance Imaging Contrast Agents.
    Morrow JR; Tóth É
    Inorg Chem; 2017 Sep; 56(17):10832. PubMed ID: 28837337
    [No Abstract]   [Full Text] [Related]  

  • 3. [Development of Magnetic Resonance Based Functional Imaging Techniques Heading Up to Theranostics ～Creating Next Generation Functional Contrast Agents～].
    Takeshita K; Matsumoto K
    Yakugaku Zasshi; 2016; 136(8):1073-4. PubMed ID: 27477719
    [No Abstract]   [Full Text] [Related]  

  • 4. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.
    Caravan P
    Acc Chem Res; 2009 Jul; 42(7):851-62. PubMed ID: 19222207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifunctional upconversion nanoparticles for targeted dual-modal imaging in rat glioma xenograft.
    Yang L; Shao B; Zhang X; Cheng Q; Lin T; Liu E
    J Biomater Appl; 2016 Sep; 31(3):400-10. PubMed ID: 27388895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular imaging with targeted contrast agents.
    Makowski MR; Wiethoff AJ; Jansen CH; Botnar RM
    Top Magn Reson Imaging; 2009 Aug; 20(4):247-59. PubMed ID: 20805735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current technological advances in magnetic resonance with critical impact for clinical diagnosis and therapy.
    Runge VM
    Invest Radiol; 2013 Dec; 48(12):869-77. PubMed ID: 24126386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and characterization of two new water-soluble endohedral metallofullerenes as magnetic resonance imaging contrast agents.
    Zhang EY; Shu CY; Feng L; Wang CR
    J Phys Chem B; 2007 Dec; 111(51):14223-6. PubMed ID: 18047312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymer diagnostics: the next generation of image contrast agents.
    Perkins AC
    J Drug Target; 1998; 6(2):79-84. PubMed ID: 9886232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paramagnetic contrast agents in magnetic resonance imaging: research at Vanderbilt University.
    Runge VM; Clanton JA; Price AC; Herzer WA; Wehr CJ; Lukehart CM; Partain CL; James AE
    Physiol Chem Phys Med NMR; 1984; 16(2):113-22. PubMed ID: 6438656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug targeting in magnetic resonance imaging.
    Weissleder R; Bogdanov A; Papisov M
    Magn Reson Q; 1992 Mar; 8(1):55-63. PubMed ID: 1567758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Light-triggered concomitant enhancement of magnetic resonance imaging contrast performance and drug release rate of functionalized amphiphilic diblock copolymer micelles.
    Li Y; Qian Y; Liu T; Zhang G; Liu S
    Biomacromolecules; 2012 Nov; 13(11):3877-86. PubMed ID: 23013152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NaDyF4 Nanoparticles as T2 Contrast Agents for Ultrahigh Field Magnetic Resonance Imaging.
    Das GK; Johnson NJ; Cramen J; Blasiak B; Latta P; Tomanek B; van Veggel FC
    J Phys Chem Lett; 2012 Feb; 3(4):524-9. PubMed ID: 26286058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging and spectroscopy methods for molecular imaging.
    Vande Velde G; Baekelandt V; Dresselaers T; Himmelreich U
    Q J Nucl Med Mol Imaging; 2009 Dec; 53(6):565-85. PubMed ID: 20016450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic barcode imaging for contrast agents.
    Hung AH; Lilley LM; Hu F; Harrison VS; Meade TJ
    Magn Reson Med; 2017 Mar; 77(3):970-978. PubMed ID: 27062518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast agents: magnetic resonance.
    Burtea C; Laurent S; Vander Elst L; Muller RN
    Handb Exp Pharmacol; 2008; (185 Pt 1):135-65. PubMed ID: 18626802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual-modality in vivo imaging using rare-earth nanocrystals with near-infrared to near-infrared (NIR-to-NIR) upconversion luminescence and magnetic resonance properties.
    Zhou J; Sun Y; Du X; Xiong L; Hu H; Li F
    Biomaterials; 2010 Apr; 31(12):3287-95. PubMed ID: 20132982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemistry of paramagnetic and diamagnetic contrast agents for Magnetic Resonance Imaging and Spectroscopy pH responsive contrast agents.
    Pérez-Mayoral E; Negri V; Soler-Padrós J; Cerdán S; Ballesteros P
    Eur J Radiol; 2008 Sep; 67(3):453-8. PubMed ID: 18455343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From signal to image: magnetic resonance imaging physics for cardiac magnetic resonance.
    Mulkern RV; Chung T
    Pediatr Cardiol; 2000; 21(1):5-17. PubMed ID: 10672610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional magnetic resonance imaging of the kidney using macromolecular contrast agents.
    Choyke PL; Kobayashi H
    Abdom Imaging; 2006; 31(2):224-31. PubMed ID: 16283582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.